Marketing-authorisation holder · United States
Apil
15 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
15 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACTONEL150MG | 30MG | 35MG | 5MG | 75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Risedronate | United States | Marketed | 1998 |
| ASACOL400mg · Tablet, delayed release | Mesalazine | United States | Not marketed | 1992 |
| ATELVIA35mg · Tablet, delayed release | Risedronate | United States | Marketed | 2010 |
| DIDRONEL200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Etidronic acid | United States | Not marketed | 1977 |
| ESTROSTEP 210.02MG,0.03MG,0.035MG; 1MG,1MG,1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Ethinyl estradiol, Norethindrone | United States | Not marketed | 1996 |
| ESTROSTEP FE0.02MG,0.03MG,0.035MG; 1MG,1MG,1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Ethinyl estradiol, Norethindrone | United States | Not marketed | 1996 |
| FEMCON FE0.035MG; 0.4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Ethinyl estradiol, Norethindrone | United States | Not marketed | 2003 |
| FEMHRT0.0025MG; 0.5MG | 0.005MG; 1MG | 0.005MG; 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Ethinyl estradiol, Norethindrone | United States | Marketed | 1999 |
| FEMTRACE0.45mg | 0.9mg | 1.8mg · Tablet | Estradiol | United States | Not marketed | 2004 |
| LO LOESTRIN FE0.01mg,0.01mg; 1mg,n/a · Tablet | Ethinyl estradiol, Norethindrone, N/a | United States | Marketed | 2010 |
| LO MINASTRIN FE0.01mg,0.01mg,n/a; 1mg,n/a,n/a · Tablet, chewable, tablet | Ethinyl estradiol, N/a, Norethindrone | United States | Not marketed | 2013 |
| MINASTRIN 24 FE0.02MG; 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Ethinyl estradiol, Norethindrone | United States | Not marketed | 2013 |
| NORCO325mg; 10mg | 325mg; 2.5mg | 325mg; 5mg | 325mg; 7.5mg · Tablet | Paracetamol, Hydrocodone | United States | Not marketed | 1997 |
| SARAFEM10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Fluoxetine | United States | Not marketed | 2006 |
| TAYTULLA0.02mg; 1mg · Capsule | Ethinyl estradiol, Norethindrone | United States | Marketed | 2013 |